All Updates

All Updates

icon
Filter
Funding
EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models
AI Drug Discovery
Jun 25, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
AI Drug Discovery

AI Drug Discovery

Jun 25, 2024

EvolutionaryScale raises USD 142 million in seed funding to develop protein-generating AI models

Funding

  • GenAI-powered protein generator EvolutionaryScale has raised USD 142 million in a seed round led by Nat Friedman, Daniel Gross, and Lux Capital, with participation from Amazon and NVenture, NVIDIA's venture arm.

  • The funds will be directed toward scaling up its model training to include data beyond proteins and to construct a uniquely versatile AI model relevant to biotech applications. Its ESM3 model is claimed to be trained on 2.78 billion proteins, allowing it to generate novel proteins intended for use in scientific discovery and material science. 

  • EvolutionaryScale is an AI biotechnology company that leverages advanced AI models to predict protein structures to support drug development, environmental remediation, and other biotech applications. Founded in 2023, the company’s technology builds on transformers-based models specialized in biological data, particularly protein molecules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.